Coya Therapeutics, Inc. (COYA)
6.22
+0.13
(+2.13%)
USD |
NASDAQ |
Dec 11, 16:00
6.35
+0.13
(+2.09%)
After-Hours: 19:25
Coya Therapeutics Shareholders Equity (Quarterly): 27.28M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Electromed, Inc. | 44.74M |
| AbbVie, Inc. | -2.642B |
| Atea Pharmaceuticals, Inc. | 315.78M |
| Picard Medical, Inc. | 7.968M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.04M |
| Total Liabilities (Quarterly) | 4.758M |
| Current Ratio | 8.733 |